Studies further indicate that removing potential copper-binding sites on Htt can eliminate copper’s pathogenic effect in HD, suggesting that Huntington’s disease is not only a polyglutamine disease but also involves copper-regulated pathogenic mechanisms (131). This evidence concerns the gene HTT and Huntington disease.